Form 4: Organogenesis Holdings Inc. Executive Reports Stock Disposal

Robert Cavorsi, Vice President of Strategy at Organogenesis Holdings Inc., disposed of shares to cover tax obligations.

Summary

• Robert Cavorsi, Vice President of Strategy at Organogenesis Holdings Inc., filed a Form 4 detailing changes in beneficial ownership.
• On February 15, 2025, Cavorsi disposed of 5,000 shares of Class A Common Stock at a price of $3.7, reducing his holdings to 134,766 shares.
• An additional 6,008 shares were disposed of on the same date at the same price, further reducing his holdings to 128,758 shares.
• The disposals were related to tax obligations.
• The form was signed by William R. Kolb, Attorney-in-Fact, on February 19, 2025.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting a stock disposal for tax purposes, indicating a neutral sentiment.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• The stock disposal may have a minor impact on shareholders due to the increased supply of shares, but the impact is likely to be minimal given the relatively small number of shares involved.

Key Dates

Keywords

Form 4, Beneficial Ownership, Stock Disposal, Organogenesis Holdings Inc., ORGO, Cavorsi, Executive, Securities